Santo Mining Competitors

Abacus Health Products (OTCMKTS:ABAHF) and Santo Mining (OTCMKTS:SANP) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Profitability

This table compares Abacus Health Products and Santo Mining's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations for Abacus Health Products and Santo Mining, as provided by MarketBeat.com.

Valuation & Earnings

This table compares Abacus Health Products and Santo Mining's top-line revenue, earnings per share (EPS) and valuation.

Acreage (OTCMKTS:ACRGF) and Santo Mining (OTCMKTS:SANP) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Profitability

This table compares Acreage and Santo Mining's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations for Acreage and Santo Mining, as provided by MarketBeat.com.

Acreage currently has a consensus target price of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher possible upside, analysts plainly believe Acreage is more favorable than Santo Mining.

Valuation & Earnings

This table compares Acreage and Santo Mining's top-line revenue, earnings per share (EPS) and valuation.

Summary

Acreage beats Santo Mining on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Santo Mining (OTCMKTS:SANP) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Profitability

This table compares Applied Biosciences and Santo Mining's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations for Applied Biosciences and Santo Mining, as provided by MarketBeat.com.

Valuation & Earnings

This table compares Applied Biosciences and Santo Mining's top-line revenue, earnings per share (EPS) and valuation.

Ayr Strategies (OTCMKTS:AYRSF) and Santo Mining (OTCMKTS:SANP) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Valuation & Earnings

This table compares Ayr Strategies and Santo Mining's top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Ayr Strategies and Santo Mining's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations for Ayr Strategies and Santo Mining, as provided by MarketBeat.com.

Ayr Strategies currently has a consensus target price of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher possible upside, analysts plainly believe Ayr Strategies is more favorable than Santo Mining.

Summary

Ayr Strategies beats Santo Mining on 2 of the 2 factors compared between the two stocks.

Can B (NASDAQ:CANB) and Santo Mining (OTCMKTS:SANP) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Earnings & Valuation

This table compares Can B and Santo Mining's gross revenue, earnings per share and valuation.

Profitability

This table compares Can B and Santo Mining's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent ratings for Can B and Santo Mining, as provided by MarketBeat.

Cansortium (OTCMKTS:CNTMF) and Santo Mining (OTCMKTS:SANP) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Earnings & Valuation

This table compares Cansortium and Santo Mining's gross revenue, earnings per share and valuation.

Profitability

This table compares Cansortium and Santo Mining's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent ratings for Cansortium and Santo Mining, as provided by MarketBeat.

Cansortium presently has a consensus target price of $1.20, indicating a potential upside of 43.13%. Given Cansortium's higher possible upside, research analysts plainly believe Cansortium is more favorable than Santo Mining.

Summary

Cansortium beats Santo Mining on 2 of the 2 factors compared between the two stocks.